SuzanneDConzenMD

Breast Cancer

Professor of Medicine, UT Southwestern Medical Center

Dr. Conzen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-4673

Fax+1 214-645-7316

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1990 - 1995
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1987 - 1990
Yale School of MedicineClass of 1987

AAP 2020
Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 2006
Join now to see all

PubMed

High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration.
Margarite D Matossian, Christine Shiang, Deniz Nesli Dolcen, Marie Dreyer, Ken Hatogai
Breast Cancer Research and Treatment. 2024-11-23
Navigate: an open-source platform for smart light-sheet microscopy.
Zach Marin, Xiaoding Wang, Dax W Collison, Conor McFadden, Jinlong Lin
Nature Methods. 2024-11-01
1 citations
Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtype.
Abigail B Clark, Suzanne D Conzen
The Journal of Steroid Biochemistry and Molecular Biology. 2024-10-01

Other

Managing the side effects of tamoxifen
Conzen SD
http://www.uptodate.com/contents/managing-the-side-effects-of-tamoxifen
UpToDate, Wolters Kluwer Health - 2012-07-16
Mechanisms of action of selective estrogen receptor modulators
Conzen SD, Ellis M
http://www.uptodate.com/contents/mechanisms-of-action-of-selective-estrogen-receptor-modulators
UpToDate, Wolters Kluwer Health - 2013-02-19

Identifying Mechanisms Linking Stress Biology To Human Breast CancerNational Cancer Institute2011–2012
The Role Of SGK1 In Triple-Negative Breast Cancer Resistance To TreatmentNational Cancer Institute2010–2011
Glucocorticoid Receptor-Mediated Survival Signaling In Breast CancerNational Cancer Institute2006–2010
Social Isolation And Response To Mammary Cancer TherapyNational Institute Of Environmental Health Sciences2007
Survival Signaling In Breast CancerNational Cancer Institute2001–2005
Glucocorticoid Mediated Signaling In Breast CancerNational Cancer Institute2002–2004